References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Lehneretal(2006)InvivocharacterisationofthenovelimidazopyridineBYK1910232-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine,apotentandhighlyselectiveinhibitorofinduciblenitric-oxidesynthase.J.Pharmacol.Exp.Ther.317181PMID:16368897
Strubetal(2006)Thenovelimidazopyridine2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine(BYK191023)isahighlyselectiveinhibitoroftheinduciblenitric-oxidesynthase.Mol.Pharmacol.68328PMID:
Tisoetal(2008)BYK191023(2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine)isanNADPH-andtime-dependentirreversibleinhibitorofinduciblenitric-oxidesynthase.Mol.Pharmacol.721244PMID:
Keywords:BYK191023dihydrochloride,supplier,Potent,selective,inhibitors,inhibits,iNOS,Nitric,Oxide,Signaling,Signalling,Inducible,NO,Synthases,BYK191023,dihydrochloride,iNOS,iNOS,TocrisBioscience